AI to fuel biotech renaissance, says Anthropic CEO Dario Amodei
AI to fuel biotech renaissance, says Anthropic CEO Dario Amodei is drawing significant interest across the industry.
Anthropic CEO Dario Amodei says artificial intelligence could trigger a biotech renaissance, accelerating breakthroughs in peptide drugs, CAR-T therapies, and programmable biology through AI-assisted design and synthetic data.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- AI a secular, long-term theme; worst of earnings firmly behind us, says Waterfield Advisors MD
- Microsoft just launched a to-do list tool that completes itself using AI - introduces Copilot Tasks
- Trane Technologies and CIT Collaborate to Establish Centre for Sustainable Refrigeration and Climate Control in India
- Citrini AI report drives sell-off, software fears
Source: Original →